FDA Approved: ZTALMY — Supplemental Application (Immedica Pharma US Inc)

View source ↗

Summary

FDA approves a supplemental application for ZTALMY (ganaxolone) submitted by Immedica Pharma US Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Tuberous Sclerosis Complex

Drugs mentioned

• ZTALMY (ganaxolone)

Snippet

SUPPL AP for ZTALMY (GANAXOLONE)